←
Qing Zhang2,635 posts
Qing Zhang avatar

Qing Zhang

@QingZhangLab

Professor at UT Southwestern Medical Center, Study hypoxia, oxygen sensing pathway and VHL pathway in cancers, including breast and kidney cancers.

◷ Joined May 2009▧ 93 Photos and videos
Molecular Cell avatar
⟳ Qing Zhang retweeted
Molecular Cell@MolecularCell·Oct 12

Online Now: PHYHD1-mediated translational control regulates renal cell carcinoma progression dlvr.​it/TVtQhR

Post attachment
UTSW Simmons Cancer Center avatar
⟳ Qing Zhang retweeted
UTSW Simmons Cancer Center@utswcancer·Sep 29

From Texas to Germany! 🌍 Today, Qing Zhang, M.D., UTSW Director of Investigative Pathology & CSO of our Breast Cancer Research Program, presented “Targeting Oxygen-Sensing Signaling in Cancer” at the HYPOX EU Forum in Essen, Germany. #CancerResearch #UTSW #Hypoxia

Post attachment
OncoAlert avatar
⟳ Qing Zhang retweeted
OncoAlert@OncoAlert·Aug 27

📣 Call for Abstracts is OPEN! DEADLINE AUGUST 28, 2026 #IKCSNA26 Join us for the 2026 International Kidney Cancer Symposium (IKCS): North America buff.ly/Wjo6fH1 IKCS: North America brings together a dynamic, multidisciplinary community of leading experts across academia, clinical care, industry, and advocacy to share innovative ideas, explore emerging trends, and shape the future of kidney cancer research and care. 🗓️ Date: November 19–21, 2026 📍 Location: Dallas, Texas 🏨 Meeting Hotel: Renaissance Dallas Hotel Have groundbreaking research to share? Submit your abstract and join the conversation that is advancing kidney cancer care. 🔗 Call for Abstracts: November 19–21 @KidneyCancer @LauraBukavinaMD @QingZhangLab @bergsa83 @mkbupathi @ADESAIONCMD @AmyLuckenbaugh @virajmaster @spsutkaMD @ChadTangMD @MVossMD @TiansterZhang @PavlosMsaouel @salvolarosa @GEVaughan1

0:10
KidneyCAN avatar
⟳ Qing Zhang retweeted
KidneyCAN@kidneycan·Jul 22

#KCRS26 starts TOMORROW! Tomorrow, researchers, clinicians, industry leaders, and advocates from around the world will come together for two days of groundbreaking science and meaningful discussion focused on advancing #KidneyCancer research. We can't wait to see everyone there! #AcceleratingCures

Post attachmentPost attachment
Katy Beckermann avatar
⟳ Qing Zhang retweeted
Katy Beckermann@katy_beckermann·Jul 22

Boston-bound for KCRS26. ✈️ Two days that pack the entire kidney cancer field, bench to bedside, into one room. So many brilliant minds in the room: @AlbigesL @HHammersMD @EJonasch @DrChoueiri @DrRanaMcKay @montypal @MikeSerzanMD @QingZhangLab @JBrugarolas @tompowles1 @DrKarieRuncie @YuWeiChenMD @paulosiqamaral @BraunMDPhD @KotechaMD @PavlosMsaouel @TiansterZhang and more that i've missed! On Friday I am giving the ASCO GU highlights, so I have been living in the RCC data. A few things showing up in the program overall: 🎯 HIF-2α inhibitors moving earlier in the disease 🔬 PSMA showing up as a target outside prostate 🤖 AI creeping into the diagnostic workflow KidneyCAN took dedicated federal funding for kidney cancer research from $0 in 2016 to more than $285M, and is still fighting for it on the Hill. 🙏 Full program 📄 bit.ly/kcrs26-program More as the sessions run. If you are here, come find me. 🧬 #KidneyCancer #RCC #GUonc #KCRS26

Post attachment
KidneyCAN avatar
⟳ Qing Zhang retweeted
KidneyCAN@kidneycan·Jul 21

The #KCRS26 Abstract Book is now available! Get an early look at the innovative research that will be presented during this year's Kidney Cancer Research Summit. From basic and translational science to clinical research, the Abstract Book offers a preview of the discoveries helping shape the future of #KidneyCancer research. 📖 View the Abstract Book: kcrs.kidneycan.org/kcrs26-ab… Then join us virtually on July 23-24 to hear these findings presented and discussed by the researchers behind the work! kcrs.kidneycan.org #AcceleratingCures

Post attachment